Abnormal uterine bleeding as a presenting sign of metastases to the uterine corpus, cervix and vagina in a breast cancer patient on tamoxifen therapy

MLA

Piura, B., et al. “Abnormal Uterine Bleeding as a Presenting Sign of Metastases to the Uterine Corpus, Cervix and Vagina in a Breast Cancer Patient on Tamoxifen Therapy.” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 83, no. 1, Jan. 1999, pp. 57–61. EBSCOhost, https://doi.org/10.1016/S0301-2115(98)00268-1.

APA

Piura, B., Yanai-Inbar, I., Rabinovich, A., Zalmanov, S., & Goldstein, J. (1999). Abnormal uterine bleeding as a presenting sign of metastases to the uterine corpus, cervix and vagina in a breast cancer patient on tamoxifen therapy. European Journal of Obstetrics & Gynecology and Reproductive Biology, 83(1), 57–61. https://doi.org/10.1016/S0301-2115(98)00268-1

Chicago

Piura, B., I. Yanai-Inbar, A. Rabinovich, S. Zalmanov, and J. Goldstein. 1999. “Abnormal Uterine Bleeding as a Presenting Sign of Metastases to the Uterine Corpus, Cervix and Vagina in a Breast Cancer Patient on Tamoxifen Therapy.” European Journal of Obstetrics & Gynecology and Reproductive Biology 83 (1): 57–61. doi:10.1016/S0301-2115(98)00268-1.